Who invested in Verdiva Bio?
Verdiva Bio's investors include OrbiMed, RA Capital Management, General Atlantic, Forbion Capital Partners and Lilly Asia Ventures.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$601Mraised across 3 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Source recorded
Verdiva Bio filed 3 raises, $372M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Verdiva Bio's own website: 7 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Verdiva Bio's investors include OrbiMed, RA Capital Management, General Atlantic, Forbion Capital Partners and Lilly Asia Ventures.
Verdiva Bio has raised $601M across 3 rounds since 2025.
Verdiva Bio's most recent round, $121M, was in May 2026.
Verdiva Bio's largest round on record is $411M (Series A), in Jan 2025.
Verdiva Bio's first round on record, in Jan 2025, was backed by OrbiMed, RA Capital Management and General Atlantic and 2 others.
Verdiva Bio's latest named round is a Series A, in Jan 2025.
Verdiva Bio is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.